ALVOBOND

· Alvotech Swiss AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALVOBOND, covering 2025-05-29 to 2025-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND [Phase 3]